Skip to Content
  • Previous Rank129
  • Revenues ($M)19,616
  • Revenue Percent Change-15.1%
  • Profits ($M)2,391
  • Profits Percent Change-49%
  • Market Value (as of March 31, 2015)80,722

The pharmaceutical giant manufactures drugs for humans as well as for livestock and poultry.

Fortune Data StoreLooking for leads, investment insights, or competitive intelligence?Get Premium Access

Company Info

CEO
John C. Lechleiter
Industry
Pharmaceuticals
Sector
Health Care
HQ Location
Indianapolis, IN
Websitehttp://www.lilly.com
Years on List21

Key Financials (last fiscal year)

$ millions% change
Revenues ($M)19,616-15.1%
Profits ($M)2,391-49%
Total Stockholder Equity15,373-
Employees39,135-
Market Value (as of March 31, 2015)80,722-

Profit Ratios

Profit as % of Revenues12.2%
Profits as % of Assets6.4%
Profits as % of Stockholder Equity15.5%

Earnings Per Share (last fiscal year)

Earnings Per Share ($)2.23
EPS % Change (from 2013)-48.4%
EPS % Change (5 year annual rate)-10.8%
EPS % Change (10 year annual rate)3%

Total Return

Total Return to Investors (2014)39.5%
Total Return to Investors (5 year, annualized)19.2%
Total Return to Investors (10 year, annualized)6.2%